7. Segment information

The Group has four operating segments, which are also the reportable segments: Europe; India, Middle East and Africa (“IMEA”); Asia Pacific (“APAC”) and Americas. The packaging solution offered by the segments consists of filling lines and other related equipment, packaging material and after-sales services.

Overview of the segments and Group Functions

Europe includes production of aseptic carton sleeves and closures, pouches as well as barrier film and fitments for bag-in-box and spouted pouches for the Group’s customers in Europe. Europe also supplies the other segments with aseptic carton sleeves and, to a lesser extent, closures from its plants in Europe. In addition, Europe includes an assembly plant for equipment used for spouted pouches. The Group’s central procurement activities, including commodity hedging, are part of Europe, with the European production entities being the main internal customers.

IMEA includes production of aseptic carton sleeves and closures as well as barrier film and fitments for bag-in-box and spouted pouches for the Group’s customers in India, Middle East and Africa. In addition, IMEA includes an assembly plant for equipment used for bag-in-box and spouted pouches.

APAC includes production of aseptic carton sleeves, carton sleeves for the chilled market, pouches as well as barrier film and fitments for bag-in-box and spouted pouches for the Group’s customers in China, Southeast Asia and Oceania. In addition, APAC supplies the other segments with aseptic carton sleeves. APAC also includes the aseptic carton filling machine assembly plant in China and the assembly of filling machines for the chilled market in Asia.

Americas includes production of aseptic carton sleeves, pouches as well as barrier film and fitments for bag-in-box and spouted pouches for the Group’s customers in North and South America. Americas also includes an assembly plant for equipment used for bag-in-box.

The Group Functions include activities that support the Group’s business, such as the global aseptic carton filling machine assembly, global technology (including R&D), information technology, marketing, finance, legal, human resources and other global support functions. Global filling machine assembly sells aseptic carton filling machines and spare parts, and provides assembly-related services, to all segments. The Group Functions are not involved in any significant transactions with third parties.

Inter-company transactions between the segments, and between the segments and the Group Functions, are eliminated in consolidation. These mainly relate to the sale of aseptic carton filling machines, aseptic carton sleeves and closures. Pricing is determined on a cost-plus basis. The Group has limited inter-segment sales of products related to the chilled carton business.

Information about the Group’s segments is reported to the Chief Operating Decision Maker (“CODM”) on a regular basis for the purposes of resource allocation and assessment of performance of the segments. The performance of the segments in 2025 has been assessed by the CODM on the basis of both adjusted EBITDA and adjusted EBIT (both measures as defined in note 9). In prior years, the performance was primarily assessed on the basis of adjusted EBITDA.

Segment financial information

The following tables present financial information about the Group’s segments and Group Functions. The same measurement basis is used when presenting the segment information as is used in the Group’s consolidated financial statements.

Segment financial information – 2025

 

 

Year ended Dec. 31, 2025

(In € million)

 

Europe

 

IMEA

 

APAC

 

Americas

 

Total segments

 

Group Functions

 

Reconciling items

 

Total

Revenue from transactions with external customers

 

1,035.7

 

445.4

 

892.4

 

874.5

 

3,248.0

 

0.7

 

 

3,248.7

Revenue from inter-segment transactions

 

389.9

 

9.7

 

45.4

 

6.1

 

451.1

 

80.2

 

(531.3)

 

Segment revenue

 

1,425.6

 

455.1

 

937.8

 

880.6

 

3,699.1

 

80.9

 

(531.3)

 

3,248.7

Cost of sales

 

(1,206.9)

 

(401.2)

 

(833.7)

 

(727.6)

 

(3,169.4)

 

(70.2)

 

531.3

 

(2,708.3)

Adjusted EBITDA1

 

296.9

 

113.5

 

224.5

 

164.4

 

799.3

 

(81.0)

 

 

718.3

of which charges due to strategic review and soft market conditions

 

33.5

 

5.8

 

11.3

 

6.9

 

57.5

 

11.8

 

 

69.3

Depreciation and amortization1

 

(84.7)

 

(42.5)

 

(99.7)

 

(50.9)

 

(277.8)

 

1.7

 

 

(276.1)

Adjusted EBIT1

 

212.2

 

71.0

 

124.8

 

113.5

 

521.5

 

(79.3)

 

 

442.2

of which charges due to strategic review and soft market conditions

 

33.5

 

5.8

 

11.3

 

6.9

 

57.5

 

11.8

 

 

69.3

Capital expenditure:2

 

(58.7)

 

(49.7)

 

(60.7)

 

(82.9)

 

(252.0)

 

(16.1)

 

 

(268.1)

PP&E and intangible assets3,4

 

(14.5)

 

(22.9)

 

(5.5)

 

(36.7)

 

(79.6)

 

(15.2)

 

 

(94.8)

Net filling lines and other related equipment4

 

(7.9)

 

(2.4)

 

(5.1)

 

(33.4)

 

(48.8)

 

(0.9)

 

 

(49.7)

Net capital expenditure2

 

(22.4)

 

(25.3)

 

(10.6)

 

(70.1)

 

(128.4)

 

(16.1)

 

 

(144.5)

Impairment losses:5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bag-in-box and spouted pouch (CGU)

 

(31.9)

 

(3.6)

 

(16.6)

 

(26.7)

 

(78.8)

 

(16.2)

 

 

(95.0)

Chilled carton (CGU)

 

 

 

(80.6)

 

 

(80.6)

 

(5.1)

 

 

(85.7)

Aseptic carton – India (CGU)

 

 

(37.6)

 

 

 

(37.6)

 

 

 

(37.6)

Individual assets5

 

(38.6)

 

(5.4)

 

(13.4)

 

(5.8)

 

(63.2)

 

(34.2)

 

4.2

 

(93.2)

Impairment losses due to strategic review and soft market conditions5

 

(70.5)

 

(46.6)

 

(110.6)

 

(32.5)

 

(260.2)

 

(55.5)

 

4.2

 

(311.5)

Other individual asset impairment losses

 

(0.3)

 

(2.6)

 

(1.1)

 

 

(4.0)

 

 

0.3

 

(3.7)

Total impairment losses

 

(70.8)

 

(49.2)

 

(111.7)

 

(32.5)

 

(264.2)

 

(55.5)

 

4.5

 

(315.2)

1

The performance of the segments for the year ended December 31, 2025 is presented with reference to both adjusted EBITDA and adjusted EBIT, excluding intra-group trademark and royalty payments. Refer to note 9 for additional details about adjusted EBITDA and adjusted EBIT (including the treatment of depreciation and amortization). In prior years, the performance of the segments was presented with reference to adjusted EBITDA only. However, adjusted EBIT is presented also for the comparative period.

2

Refer to note 11 for additional details about capital expenditure and net capital expenditure.

3

PP&E (excluding filling lines and other related equipment) and intangible assets.

4

Group Functions may report positive net filling lines and other related equipment capital expenditure if the capital expenditure of the global aseptic carton filling machine assembly during a period is smaller than the payments it received under intra-group sales of filling machines. This could also happen occasionally in the case of PP&E and intangible asset capital expenditure, excluding filling lines and other related equipment.

5

See notes 4, 9 and 1214 for additional information about the impairment losses. The impairment losses relating to individual assets tested separately for impairment are recognized in all segments and in Group Functions. The impairment loss of the capitalized development costs (€13.5 million) is recognized in Group Functions.

Segment financial information – 2024

 

 

Year ended Dec. 31, 2024

(In € million)

 

Europe

 

IMEA

 

APAC

 

Americas

 

Total segments

 

Group Functions

 

Reconciling items

 

Total

Revenue from transactions with external customers

 

1,044.7

 

456.4

 

938.1

 

888.6

 

3,327.8

 

0.7

 

 

3,328.5

Revenue from inter-segment transactions

 

379.6

 

17.6

 

48.5

 

5.7

 

451.4

 

84.9

 

(536.3)

 

Segment revenue

 

1,424.3

 

474.0

 

986.6

 

894.3

 

3,779.2

 

85.6

 

(536.3)

 

3,328.5

Cost of sales

 

(1,175.4)

 

(370.0)

 

(791.6)

 

(682.0)

 

(3,019.0)

 

(74.6)

 

536.3

 

(2,557.3)

Adjusted EBITDA1

 

308.4

 

122.0

 

259.7

 

208.7

 

898.8

 

(79.3)

 

 

819.5

Depreciation and amortization1

 

(83.0)

 

(42.1)

 

(93.8)

 

(50.0)

 

(268.9)

 

(0.1)

 

 

(269.0)

Adjusted EBIT1

 

225.4

 

79.9

 

165.9

 

158.7

 

629.9

 

(79.4)

 

 

550.5

Capital expenditure:2

 

(79.1)

 

(52.9)

 

(110.2)

 

(74.8)

 

(317.0)

 

9.8

 

 

(307.2)

PP&E and intangible assets3,4

 

(27.5)

 

(29.5)

 

(35.5)

 

(32.0)

 

(124.5)

 

(2.1)

 

 

(126.6)

Net filling lines and other related equipment4

 

(6.6)

 

(3.6)

 

(16.4)

 

(22.7)

 

(49.3)

 

12.0

 

 

(37.3)

Net capital expenditure2

 

(34.1)

 

(33.1)

 

(51.9)

 

(54.7)

 

(173.8)

 

9.9

 

 

(163.9)

Impairment losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chilled carton

 

 

 

(17.3)

 

 

(17.3)

 

 

 

(17.3)

Other

 

(1.6)

 

(2.8)

 

(4.3)

 

(0.6)

 

(9.3)

 

 

 

(9.3)

Total impairment losses

 

(1.6)

 

(2.8)

 

(21.6)

 

(0.6)

 

(26.6)

 

 

 

(26.6)

1

The performance of the segments for the year ended December 31, 2025 is presented with reference to both adjusted EBITDA and adjusted EBIT, excluding intra-group trademark and royalty payments. Refer to note 9 for additional details about adjusted EBITDA and adjusted EBIT (including the treatment of depreciation and amortization). In prior years, the performance of the segments was presented with reference to adjusted EBITDA only. However, adjusted EBIT is presented also for the comparative period.

2

Refer to note 11 for additional details about capital expenditure and net capital expenditure.

3

PP&E (excluding filling lines and other related equipment) and intangible assets.

4

Group Functions may report positive net filling lines and other related equipment capital expenditure if the capital expenditure of the global aseptic carton filling machine assembly during a period is smaller than the payments it received under intra-group sales of filling machines. This could also happen occasionally in the case of PP&E and intangible asset capital expenditure, excluding filling lines and other related equipment.

Disaggregation of segment revenue

The following tables present revenue from transactions with external customers for the segments, split by major product/service line.

Disaggregation of segment revenue by major product/service lines 2025

 

 

Year ended December 31, 2025

(In € million)

 

Europe

 

IMEA

 

APAC

 

Americas

 

Total segments

 

Group Functions

 

Total

Revenue from the sale of carton, bag-in-box and spouted pouch

 

923.1

 

367.4

 

760.1

 

777.8

 

2,828.4

 

 

2,828.4

Filling line and other related equipment revenue

 

49.1

 

41.0

 

73.0

 

46.7

 

209.8

 

 

209.8

Service revenue

 

63.5

 

37.0

 

59.3

 

50.0

 

209.8

 

0.5

 

210.3

Other revenue

 

 

 

 

 

 

0.2

 

0.2

Total revenue

 

1,035.7

 

445.4

 

892.4

 

874.5

 

3,248.0

 

0.7

 

3,248.7

Disaggregation of segment revenue by major product/service lines 2024

 

 

Year ended December 31, 2024

(In € million)

 

Europe

 

IMEA

 

APAC

 

Americas

 

Total segments

 

Group Functions

 

Total

Revenue from the sale of cartons, bag-in-boxes and spouted pouch

 

910.3

 

391.7

 

799.0

 

788.6

 

2,889.6

 

 

2,889.6

Filling line and other related equipment revenue

 

72.7

 

29.3

 

75.2

 

49.3

 

226.5

 

0.2

 

226.7

Service revenue

 

61.7

 

35.4

 

63.9

 

50.7

 

211.7

 

0.3

 

212.0

Other revenue

 

 

 

 

 

 

0.2

 

0.2

Total revenue

 

1,044.7

 

456.4

 

938.1

 

888.6

 

3,327.8

 

0.7

 

3,328.5

Geographic information

The Group operates in total 27 plants worldwide that mainly produce aseptic carton sleeves and film and fitments for bag-in-box and spouted pouches, but also chilled carton sleeves, closures and pouches. It also has a number of equipment assembly plants and training- and development-related centers.

The following table provides an overview of the location of the Group’s production and equipment assembly plants and its different centers as of December 31, 2025.

Overview of the location of the Group’s production and equipment assembly plants and its different centers

 

 

Production plants

 

Equipment assembly plants

 

Training centers

 

R&D centers

 

Technology centers

 

Packaging development centers

China

 

4

 

2

 

1

 

1

 

1

 

 

USA

 

4

 

1

 

 

 

1

 

 

 

 

Germany

 

3

 

1

 

1

 

1

 

1

 

1

India

 

3

 

1

 

 

 

 

 

 

 

 

Brazil

 

2

 

 

 

1

 

 

 

 

 

 

Netherlands

 

2

 

 

 

 

 

 

 

 

 

 

Australia

 

1

 

 

 

 

 

 

 

 

 

 

Austria

 

1

 

 

 

 

 

 

 

 

 

 

Mexico

 

1

 

 

 

 

 

 

 

 

 

 

Russia

 

1

 

 

 

 

 

 

 

 

 

 

Saudi Arabia

 

1

 

 

 

 

 

 

 

 

 

 

South Korea

 

1

 

 

 

 

 

 

 

 

 

 

Switzerland

 

1

 

 

 

 

 

1

 

 

 

 

Taiwan

 

1

 

 

 

 

 

 

 

 

 

 

Thailand

 

1

 

 

 

1

 

 

 

 

 

 

Spain

 

 

 

1

 

 

 

1

 

 

 

 

UAE

 

 

 

 

 

1

 

 

 

1

 

 

Total Group

 

27

 

6

 

5

 

5

 

3

 

1

The construction of the Group’s first aseptic carton production plant in India was completed in December 2024. Production started in January 2025. In the second quarter of 2024, the Group moved its production of chilled carton in China from Shanghai to a new plant in Suzhou. These production plants are all leased by the Group.

In the third quarter of 2025, the Group initiated the closure of one of the two bag-in-box production plants in the Netherlands to streamline the European bag-in-box operations. The plant is expected to be vacated in the second half of 2026. The bag-in-box and spouted pouch production in the leased production plant in Chile was relocated to Brazil in 2025. See also notes 4, 9, 11 and 13.

The following table includes information about the Group’s non-current assets on a country basis. Non-current assets exclude financial instruments, deferred tax assets and net defined benefit assets.

Geographic information – non-current assets

(In € million)

 

Year ended
Dec. 31, 2025

 

Year ended
Dec. 31, 2024

Germany

 

911.5

 

926.6

USA

 

876.3

 

1,022.7

China

 

831.0

 

1,012.7

United Arab Emirates

 

576.0

 

587.4

Thailand

 

503.5

 

532.0

Switzerland1

 

459.5

 

499.9

Other countries

 

1,415.1

 

1,600.1

Total non-current assets

 

5,572.9

 

6,181.4

1

The Company’s country of domicile is Switzerland.

The non-current assets are reported based on the geographic location of the business operations. The non-current assets are predominantly located in the countries in which the Group’s production and assembly plants are located. The Group’s intellectual property is primarily held by a company based in Switzerland.

The following table includes information about the Group’s revenue from external customers on a country basis.

Geographic information – revenue from external customers

(In € million)

 

Year ended
Dec. 31, 2025

 

Year ended
Dec. 31, 2024

USA

 

392.8

 

429.4

China

 

372.0

 

408.6

Germany

 

277.6

 

289.3

Switzerland

 

17.4

 

15.1

Other countries

 

2,188.9

 

2,186.1

Total revenue from external customers

 

3,248.7

 

3,328.5

Revenue is reported based on the geographic location of customers. The customer base of the Group includes international companies, large national and regional companies as well as small local companies.

Information about major customers

The Group does not have revenue from transactions with a single external customer amounting to 10% or more of the Group’s revenue in any of the periods presented.

Share this page